Cellular biomedicine group, inc. (CBMG)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Biomedical

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

95

0

-

-

-

-

-

-

-

-

-

-

-

Revenues - Products

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

4

-

-

-

-

-

-

-

-

Revenues - Services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

254

3

28

0

0

0

Net sales and revenue

-

-

-

-

-

-

-

-

-

-

-

-

98

-

10

71

488

620

624

656

603

385

0

118

61

109

95

0

0

-

-

-

-

-

-

-

-

-

-

Net sales and revenue

0

290

0

0

49

25

70

77

50

-

106

62

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

194

78

-

3

-

-

-

-

Cost of services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

Gross profit (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

109

50

254

3

28

0

0

0

Operating expenses:
Cost of sales

0

54

0

0

8

21

37

54

22

-

55

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

37

-

9

323

503

544

443

398

494

149

0

51

40

137

158

0

0

-

7

85

27

-

-

-

-

-

-

Consulting operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

403

-

-

-

-

-

-

-

-

-

-

General and administrative

3,431

3,503

3,326

3,180

3,447

3,594

3,315

3,121

3,188

3,252

3,023

3,319

3,185

3,031

2,790

3,072

2,775

3,152

3,467

3,768

2,680

2,903

1,946

1,642

1,382

2,004

1,398

1,578

4,179

808

606

1,054

985

242

348

318

311

171

335

Selling and marketing

0

19

38

41

42

56

84

92

74

80

85

76

117

82

124

39

178

208

190

161

149

228

21

44

21

-25

8

46

28

171

124

145

29

27

13

48

12

16

32

Research and development

7,759

9,512

13,126

9,062

5,968

6,164

6,545

6,166

5,273

4,140

4,076

3,349

3,044

3,206

2,897

2,972

2,398

2,604

2,190

1,322

1,455

1,116

812

719

498

725

196

639

480

2,215

687

55

255

-

-

-

-

-

-

Impairment of investments

240

0

0

0

0

-

2,884

29

-

-

-

0

-

-

4,611

-

-

0

0

0

123

1,427

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment on non-current assets

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

11,430

13,089

16,491

12,284

9,466

9,837

12,868

9,464

8,559

7,505

7,240

6,783

6,384

6,345

10,433

6,408

5,856

6,510

6,290

5,650

4,902

5,825

2,780

2,458

1,942

2,439

1,761

2,264

5,092

3,389

1,419

1,255

1,271

269

361

367

324

187

367

Operating loss

-11,430

-12,799

-16,491

-12,284

-9,416

-9,811

-12,797

-9,387

-8,508

-7,436

-7,133

-6,720

-6,286

-6,287

-10,423

-6,336

-5,367

-5,890

-5,666

-4,993

-4,298

-5,440

-2,780

-2,340

-1,881

-2,329

-1,666

-2,264

-5,092

-3,273

-1,422

-1,146

-1,220

-14

-358

-339

-324

-187

-367

Other (expense) income:
Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

257

0

0

0

0

17

-1

-2

-3

2

2

Interest income, net

12

177

352

182

97

251

18

116

5

19

23

40

49

21

22

18

17

12

8

5

15

13

0

0

0

-0

0

0

0

0

0

0

1

-

0

-

-

-

-

Gain (loss) on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52

0

0

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Other expense, net

-127

-67

274

7

-14

1,040

38

84

9

493

907

476

77

125

-17

7

16

127

492

13

-2

-22

-0

74

20

54

-16

22

-66

0

28

0

0

710

-232

0

0

0

0

Total other (expense) income

-115

110

627

189

82

1,292

56

201

14

513

931

516

126

146

5

25

33

140

500

19

12

-8

0

74

20

311

-16

23

-323

0

28

0

1

797

-283

2

4

2

2

Loss before taxes

-11,545

-12,689

-15,864

-12,095

-9,334

-8,519

-12,741

-9,186

-8,494

-6,922

-6,202

-6,203

-6,159

-6,140

-10,417

-6,311

-5,334

-5,750

-5,165

-4,974

-4,286

-5,448

-2,780

-2,265

-1,861

-2,018

-1,682

-2,241

-5,416

-3,272

-1,394

-1,145

-1,219

228

-75

-341

-328

-189

-369

Income taxes provision

1

-2

-0

1

2

0

2

0

2

0

0

0

2

-1

243

886

-1,124

-758

-23

52

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,448

-2,780

-2,265

-1,861

-

-1,682

-2,241

-

-

-

-

-

-

-

-

-

-

-

Income (loss) from discontinued Consulting segment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,646

263

-

-

-

-

-

-

-

-

-

-

-

Loss on discontinued operations, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-386

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Loss on discontinued operations, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-43

-4,408

1,414

-

2,259

-263

-

-

-

-

-

-

-

-

-

-

-

Net loss

-11,547

-12,686

-15,863

-12,096

-9,336

-8,519

-12,743

-9,186

-8,496

-6,922

-6,202

-6,203

-6,161

-6,139

-10,661

-7,197

-4,210

-4,991

-5,142

-5,026

-4,287

-5,530

-2,823

-6,674

-446

-6,453

576

-2,504

-5,416

-3,272

-1,394

-1,145

-1,219

228

-75

-341

-328

-189

-369

Other comprehensive loss:
Cumulative translation adjustment

-436

311

-303

-395

396

57

-834

-1,120

818

329

291

292

53

-429

-58

-271

16

-144

-225

42

19

23

-1

4

-11

24

24

31

-1

5

6

-4

5

-

-

-

-

-

-

Unrealized loss on investments, net of tax

-

-

-

-

-

-

-

-

-

-

0

-240

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on investments, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-11,115

16,416

-7,920

-1,520

10,631

-2,568

-904

-1,005

4,042

-521

746

-210

-112

-622

0

0

0

0

-138

-79

-102

148

0

0

Reclassification adjustments, net of tax, in connection with other-than-temporary impairment of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,557

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification adjustments, net of tax, in connection with other-than-temporary impairment of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other comprehensive loss

-436

311

-303

-395

396

57

-834

-1,120

818

329

291

52

53

-429

-5,616

-11,387

16,432

-8,064

-1,745

10,673

-2,548

-880

-1,007

4,047

-533

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-11,984

-12,375

-16,167

-12,492

-8,940

-8,462

-13,578

-10,306

-7,678

-6,593

-5,910

-6,151

-6,108

-6,568

-16,277

-18,584

12,222

-13,056

-6,887

5,647

-6,835

-6,411

-3,830

-2,626

-979

-5,682

390

-2,584

-6,040

-3,266

-1,387

-1,150

-1,213

89

-154

-443

-179

-189

-369

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.59

-0.30

-0.29

-0.25

-

-0.27

-0.39

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.59

-0.30

-0.29

-0.25

-

-0.27

-0.39

-

-

-

-

-

-

-

-

-

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.01

0.00

-0.56

0.19

-

0.37

-0.05

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.01

0.00

-0.56

0.19

-

0.36

-0.05

-

-

-

-

-

-

-

-

-

-

-

Net loss per share:
Basic

-

-

-

-

-

-

-

-

-

-

-

-

-0.43

-

-0.75

-0.52

-0.35

-0.43

-0.44

-0.44

-0.39

-0.57

-0.31

-0.85

-0.06

-0.87

0.09

-0.44

-1.16

-

-0.45

-

-

-

-

-

-

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-0.43

-

-0.75

-0.52

-0.35

-0.43

-0.44

-0.44

-0.39

-0.57

-0.31

-0.85

-0.06

-0.87

0.09

-0.44

-1.16

-

-0.45

-

-

-

-

-

-

-

-

Basic and diluted

-0.60

-0.67

-0.82

-0.63

-0.51

-0.44

-0.72

-0.53

-0.51

-

-0.43

-0.43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.40

-0.42

0.00

0.00

0.00

0.00

0.00

0.00

Weighted average common shares outstanding:
Basic

-

-

-

-

-

-

-

-

-

-

-

-

14,281

-

14,128

13,737

11,884

11,695

11,622

11,531

11,039

10,052

9,131

7,829

7,494

6,628

6,155

5,719

4,668

-

3,099

-

-

-

-

-

-

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

14,281

-

14,128

13,737

11,884

11,695

11,622

11,531

11,039

10,052

9,131

7,829

7,494

6,554

6,229

5,719

4,668

-

3,099

-

-

-

-

-

-

-

-

Basic and diluted

19,340

19,301

19,256

19,223

18,152

19,130

17,604

17,487

16,742

-

14,349

14,298

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,896

2,877

-

152,968

-

-

-

-

Basic and diluted:

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

151,152

150,097

148,042

146,897